Do you continue calcineurin inhibitor-based immunosuppression after a failed kidney transplant that remains in situ, to reduce HLA sensitization and preserve retransplantation options?
1 Answer
Mednet MemberInvited Expert
Nephrology · University of Alabama Birmingham
Answered on
Yes, I do. Mostly if patients continue to have some residual function and have a living donor. I would target lower levels ~2-4.
This is a nice review of failed allograft management by Agrawal & Pavlakis, PMID 31135561.
Join for free or sign in to see the full answer